Synopsis
Synopsis
0
VMF
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Schembl34274
2. Ft-0603494
3. Ft-0656045
Molecular Weight | 676.8 g/mol |
---|---|
Molecular Formula | C34H48N2O10S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 10 |
Exact Mass | 676.30296691 g/mol |
Monoisotopic Mass | 676.30296691 g/mol |
Topological Polar Surface Area | 191 Ų |
Heavy Atom Count | 47 |
Formal Charge | 0 |
Complexity | 415 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 6 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Atropine sulfate |
Drug Label | Atropine Sulfate Injection, USP is a sterile, nonpyrogenic isotonic solution of atropine sulfate monohydrate in water for injection with sodium chloride sufficient to render the solution isotonic. It is administered parenterally by subcutaneous, intr... |
Active Ingredient | Atropine sulfate |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | 1% |
Market Status | Prescription |
Company | Akorn |
2 of 2 | |
---|---|
Drug Name | Atropine sulfate |
Drug Label | Atropine Sulfate Injection, USP is a sterile, nonpyrogenic isotonic solution of atropine sulfate monohydrate in water for injection with sodium chloride sufficient to render the solution isotonic. It is administered parenterally by subcutaneous, intr... |
Active Ingredient | Atropine sulfate |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | 1% |
Market Status | Prescription |
Company | Akorn |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
47
PharmaCompass offers a list of Atropine Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Atropine Sulfate manufacturer or Atropine Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Atropine Sulfate manufacturer or Atropine Sulfate supplier.
PharmaCompass also assists you with knowing the Atropine Sulfate API Price utilized in the formulation of products. Atropine Sulfate API Price is not always fixed or binding as the Atropine Sulfate Price is obtained through a variety of data sources. The Atropine Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Chauvin Brand of Atropine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chauvin Brand of Atropine, including repackagers and relabelers. The FDA regulates Chauvin Brand of Atropine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chauvin Brand of Atropine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Chauvin Brand of Atropine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Chauvin Brand of Atropine supplier is an individual or a company that provides Chauvin Brand of Atropine active pharmaceutical ingredient (API) or Chauvin Brand of Atropine finished formulations upon request. The Chauvin Brand of Atropine suppliers may include Chauvin Brand of Atropine API manufacturers, exporters, distributors and traders.
click here to find a list of Chauvin Brand of Atropine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Chauvin Brand of Atropine DMF (Drug Master File) is a document detailing the whole manufacturing process of Chauvin Brand of Atropine active pharmaceutical ingredient (API) in detail. Different forms of Chauvin Brand of Atropine DMFs exist exist since differing nations have different regulations, such as Chauvin Brand of Atropine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Chauvin Brand of Atropine DMF submitted to regulatory agencies in the US is known as a USDMF. Chauvin Brand of Atropine USDMF includes data on Chauvin Brand of Atropine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Chauvin Brand of Atropine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Chauvin Brand of Atropine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Chauvin Brand of Atropine Drug Master File in Japan (Chauvin Brand of Atropine JDMF) empowers Chauvin Brand of Atropine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Chauvin Brand of Atropine JDMF during the approval evaluation for pharmaceutical products. At the time of Chauvin Brand of Atropine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Chauvin Brand of Atropine suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Chauvin Brand of Atropine Drug Master File in Korea (Chauvin Brand of Atropine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Chauvin Brand of Atropine. The MFDS reviews the Chauvin Brand of Atropine KDMF as part of the drug registration process and uses the information provided in the Chauvin Brand of Atropine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Chauvin Brand of Atropine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Chauvin Brand of Atropine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Chauvin Brand of Atropine suppliers with KDMF on PharmaCompass.
A Chauvin Brand of Atropine CEP of the European Pharmacopoeia monograph is often referred to as a Chauvin Brand of Atropine Certificate of Suitability (COS). The purpose of a Chauvin Brand of Atropine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Chauvin Brand of Atropine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Chauvin Brand of Atropine to their clients by showing that a Chauvin Brand of Atropine CEP has been issued for it. The manufacturer submits a Chauvin Brand of Atropine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Chauvin Brand of Atropine CEP holder for the record. Additionally, the data presented in the Chauvin Brand of Atropine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Chauvin Brand of Atropine DMF.
A Chauvin Brand of Atropine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Chauvin Brand of Atropine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Chauvin Brand of Atropine suppliers with CEP (COS) on PharmaCompass.
A Chauvin Brand of Atropine written confirmation (Chauvin Brand of Atropine WC) is an official document issued by a regulatory agency to a Chauvin Brand of Atropine manufacturer, verifying that the manufacturing facility of a Chauvin Brand of Atropine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Chauvin Brand of Atropine APIs or Chauvin Brand of Atropine finished pharmaceutical products to another nation, regulatory agencies frequently require a Chauvin Brand of Atropine WC (written confirmation) as part of the regulatory process.
click here to find a list of Chauvin Brand of Atropine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Chauvin Brand of Atropine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Chauvin Brand of Atropine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Chauvin Brand of Atropine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Chauvin Brand of Atropine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Chauvin Brand of Atropine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Chauvin Brand of Atropine suppliers with NDC on PharmaCompass.
Chauvin Brand of Atropine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Chauvin Brand of Atropine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Chauvin Brand of Atropine GMP manufacturer or Chauvin Brand of Atropine GMP API supplier for your needs.
A Chauvin Brand of Atropine CoA (Certificate of Analysis) is a formal document that attests to Chauvin Brand of Atropine's compliance with Chauvin Brand of Atropine specifications and serves as a tool for batch-level quality control.
Chauvin Brand of Atropine CoA mostly includes findings from lab analyses of a specific batch. For each Chauvin Brand of Atropine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Chauvin Brand of Atropine may be tested according to a variety of international standards, such as European Pharmacopoeia (Chauvin Brand of Atropine EP), Chauvin Brand of Atropine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Chauvin Brand of Atropine USP).